+

TN2009000530A1 - N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors - Google Patents

N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors

Info

Publication number
TN2009000530A1
TN2009000530A1 TNP2009000530A TN2009000530A TN2009000530A1 TN 2009000530 A1 TN2009000530 A1 TN 2009000530A1 TN P2009000530 A TNP2009000530 A TN P2009000530A TN 2009000530 A TN2009000530 A TN 2009000530A TN 2009000530 A1 TN2009000530 A1 TN 2009000530A1
Authority
TN
Tunisia
Prior art keywords
compound
treatment
piperidinedicarboxamide
ethoxyethyl
pyridinyl
Prior art date
Application number
TNP2009000530A
Other languages
English (en)
Inventor
Fumiaki Yokokawa
Takeru Ehara
Shimpei Kawakami
Osamu Irie
Masaki Suzuki
Yuko Hitomi
Atsushi Toyao
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39926743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2009000530(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2009000530A1 publication Critical patent/TN2009000530A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TNP2009000530A 2007-06-25 2009-12-17 N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors TN2009000530A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07012412 2007-06-25
EP07111290 2007-06-28
PCT/EP2008/057964 WO2009000811A1 (fr) 2007-06-25 2008-06-23 Composés organiques

Publications (1)

Publication Number Publication Date
TN2009000530A1 true TN2009000530A1 (en) 2011-03-31

Family

ID=39926743

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2009000530A TN2009000530A1 (en) 2007-06-25 2009-12-17 N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors

Country Status (26)

Country Link
US (2) US8383650B2 (fr)
EP (2) EP2181105B1 (fr)
JP (1) JP5086433B2 (fr)
KR (1) KR101238479B1 (fr)
CN (1) CN101687847B (fr)
AR (1) AR067132A1 (fr)
AU (1) AU2008267287B2 (fr)
BR (1) BRPI0813900A2 (fr)
CA (1) CA2689109A1 (fr)
CL (1) CL2008001872A1 (fr)
CO (1) CO6251267A2 (fr)
CR (1) CR11153A (fr)
CU (1) CU23842B1 (fr)
EA (1) EA016446B1 (fr)
EC (1) ECSP099825A (fr)
ES (2) ES2543641T3 (fr)
GT (1) GT200900324A (fr)
HN (1) HN2009003463A (fr)
IL (1) IL202494A0 (fr)
MA (1) MA31538B1 (fr)
NZ (1) NZ582098A (fr)
PE (1) PE20090425A1 (fr)
SG (1) SG182223A1 (fr)
TN (1) TN2009000530A1 (fr)
TW (1) TWI404714B (fr)
WO (1) WO2009000811A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0813900A2 (pt) 2007-06-25 2014-12-30 Novartis Ag Derivados de n5-(2-etoxietil)-n3-(2-piridinil)-3,5-piperidinodicarboxa mida para uso como inibidores de renina
US20180048921A1 (en) * 2016-08-12 2018-02-15 Microsoft Technology Licensing, Llc Real-time playback diagnostics

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2090956T3 (es) 1991-12-18 1996-10-16 Schering Corp Imidazolil o imidazolilalquil sustituido con un anillo heterociclico de cuatro o cinco miembros que contiene nitrogeno.
IL111176A0 (en) 1993-10-07 1994-12-29 Du Pont Merck Pharma Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them
HUP9900926A3 (en) 1995-09-07 2002-12-28 Hoffmann La Roche New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
EP0862435A4 (fr) 1995-11-22 1999-02-03 Merck & Co Inc Inhibiteurs de la farnesyl-proteine transferase
WO1999009984A1 (fr) 1997-08-28 1999-03-04 Merck & Co., Inc. Modulateurs de pyrrolidine et de piperidine de l'activite du recepteur de chemokine
WO1999065867A1 (fr) 1998-06-17 1999-12-23 Du Pont Pharmaceuticals Company Acides hydroxamiques cycliques utilises en tant qu'inhibiteurs de metalloproteases
US6274735B1 (en) 1998-08-10 2001-08-14 Hoffmann-La Roche Inc. Process and intermediates for preparation of substituted piperidines
JP2002528543A (ja) 1998-10-30 2002-09-03 メルク エンド カムパニー インコーポレーテッド トロンビン阻害剤
AU3386700A (en) 1999-03-02 2000-09-21 Merck & Co., Inc. 3-thienyl and 3-furanyl pyrrolidine modulators of chemokine receptor activity
AU3389300A (en) 1999-03-02 2000-09-21 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6362201B1 (en) 1999-03-02 2002-03-26 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
WO2000063173A1 (fr) 1999-04-14 2000-10-26 F. Hoffmann-La Roche Ag Procede de preparation de piperidines substituees
US6376672B1 (en) 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
US6197959B1 (en) 1999-04-27 2001-03-06 Hoffmann-La Roche Inc. Piperidine derivatives
KR20030009391A (ko) 2000-03-17 2003-01-29 브리스톨-마이어스 스퀴브 파마 컴파니 기질 금속단백분해효소 및 TNF-α의 억제제인 시클릭β-아미노산 유도체
FR2811673B1 (fr) 2000-07-17 2002-09-13 Rhodia Chimie Sa Utilisation de composes insatures comprenant un heterocycle comme stabilisants de polymeres halogenes
EP1326619A2 (fr) 2000-10-11 2003-07-16 Merck & Co., Inc. Modulateurs a base de pyrrolidine d'activite de recepteur de chimiokines ccr5
US20060079533A1 (en) 2001-03-23 2006-04-13 Nieman James A Methods of treating alzheimer's disease
US20030095958A1 (en) 2001-04-27 2003-05-22 Bhisetti Govinda R. Inhibitors of bace
AU2002341715A1 (en) 2001-09-17 2003-04-01 Bristol-Myers Squibb Company Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
WO2003031443A1 (fr) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Antibiotiques a action duale renfermant une oxazolidinone et une quinolone ou une fraction de naphthyridinone
CA2483241C (fr) 2002-04-29 2011-05-31 Actelion Pharmaceuticals Ltd Nouveaux derives de diazabicyclononene
JP4271148B2 (ja) 2002-05-20 2009-06-03 ブリストル−マイヤーズ スクイブ カンパニー 置換シクロアルキルp1’c型肝炎ウイルスインヒビター
PL374860A1 (en) 2002-07-09 2005-11-14 Bristol-Myers Squibb Company Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
US20040204455A1 (en) 2003-04-10 2004-10-14 Cody Wayne Livingston Piperidine derivative rennin inhibitors
US20040214832A1 (en) 2003-04-10 2004-10-28 Cuiman Cai Piperazine derivative renin inhibitors
US20060217371A1 (en) 2003-04-28 2006-09-28 Olivier Bezencon Diazabicyclononene and tetrahydropyriddine derivatives as renin inhibitors
RU2005136986A (ru) 2003-04-29 2006-05-27 Актелион Фармасьютикалз Лтд. (Ch) Новые 3,4-дизамещенные производные 1,2,3,6-тетрагидропиридина
BRPI0409878A (pt) 2003-04-30 2006-05-23 Actelion Pharmaceuticals Ltd compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
KR20060008937A (ko) 2003-04-30 2006-01-27 액테리온 파마슈티칼 리미티드 레닌 억제제로서 3-위치에 헤테로원자를 갖는9-아자비사이클로[3.3.1]논-6-엔 유도체
KR20060006069A (ko) 2003-04-30 2006-01-18 액테리온 파마슈티칼 리미티드 아자비사이클로노넨 유도체
WO2004096116A2 (fr) 2003-05-02 2004-11-11 Actelion Pharmaceuticals Ltd Derives de diazabicyclononene
US7144907B2 (en) 2003-09-03 2006-12-05 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
TW200900399A (en) 2003-10-01 2009-01-01 Speedel Experimenta Ag Organic compounds
CA2540543A1 (fr) 2003-10-09 2005-05-06 Actelion Pharmaceuticals Ltd Derives de tetrahydropyridine
CA2600973C (fr) 2003-11-26 2012-08-07 Novartis Ag Acide .delta.-amino-.gamma.-hydroxy-.omega.-arylalcanoique
PL1689712T3 (pl) 2003-11-26 2010-01-29 Novartis Ag Pochodne 4-fenylopiperydyny jako inhibitory reniny
BRPI0506490A (pt) 2004-01-23 2007-02-13 Speedel Experimenta Ag compostos orgánicos
ES2357585T3 (es) 2004-01-23 2011-04-27 Novartis Ag Derivados de aminoalcoholes y su actividad como inhibidores de la renina.
BRPI0507067A (pt) 2004-01-23 2007-06-12 Speedel Experimenta Ag diamino álcoois e seu uso como inibidores de renina
TW200536539A (en) 2004-03-19 2005-11-16 Speedel Experimenta Ag Organic compounds
JP4927704B2 (ja) 2004-03-19 2012-05-09 シュペーデル・エクスペリメンタ・アーゲー 有機化合物
AR053406A1 (es) 2004-07-09 2007-05-09 Speedel Experimenta Ag Derivados de piperidina como inhibidores de renina. composiciones farmaceuticas
TW200631929A (en) 2004-12-10 2006-09-16 Speedel Experimenta Ag ω -phenyloctanamides
GB0428250D0 (en) 2004-12-23 2005-01-26 Novartis Ag Organic compounds
GB0428526D0 (en) 2004-12-30 2005-02-09 Novartis Ag Organic compounds
GB0500784D0 (en) 2005-01-14 2005-02-23 Novartis Ag Organic compounds
GB0504850D0 (en) 2005-03-09 2005-04-13 Novartis Ag Organic compounds
JP2008532983A (ja) 2005-03-11 2008-08-21 シュペーデル・エクスペリメンタ・アーゲー レニン阻害剤として有用な複素環置換アルカンアミド
GB0505969D0 (en) 2005-03-23 2005-04-27 Novartis Ag Organic compounds
TW200722424A (en) 2005-03-31 2007-06-16 Speedel Experimenta Ag Substituted piperidines
US20090270380A1 (en) 2005-03-31 2009-10-29 Peter Herold 3,4,5-Substituted Piperidines as Renin Inhibitors
GB0508992D0 (en) * 2005-05-03 2005-06-08 Novartis Ag Organic compounds
GB0510810D0 (en) 2005-05-26 2005-06-29 Novartis Ag Organic compounds
GB0511063D0 (en) 2005-05-31 2005-07-06 Novartis Ag Organic compounds
GB0514203D0 (en) * 2005-07-11 2005-08-17 Novartis Ag Organic compounds
WO2007031558A1 (fr) 2005-09-17 2007-03-22 Speedel Experimenta Ag Amides d'acide alcanoïque bicyclo- ou spiro-substitués
PL1937248T3 (pl) 2005-09-17 2010-11-30 Novartis Ag Amidy kwasów alkanowych podstawione nasyconymi grupami O-heterocyklicznymi
PE20071079A1 (es) * 2005-11-15 2007-12-16 Cytokinetics Inc Compuestos de piperidina como inhibidores de la proliferacion celular
JP5306821B2 (ja) * 2005-12-30 2013-10-02 ノバルティス アーゲー レニン阻害剤としての3,5−置換ピペリジン化合物
EP1816122A3 (fr) * 2006-01-19 2007-09-19 Speedel Experimenta AG Pipéridines substituées 3,4,5 en tant que composants thérapeutiques
EP1979323A1 (fr) 2006-01-30 2008-10-15 Speedel Experimenta AG Procede de preparation de composes organiques
EP2044059A1 (fr) 2006-06-08 2009-04-08 Speedel Experimenta AG Pipéridines 2,5-disubstituées
GB0611696D0 (en) 2006-06-13 2006-07-26 Novartis Ag Organic compounds
GB0611697D0 (en) 2006-06-13 2006-07-26 Novartis Ag Organic compounds
TW200831463A (en) 2006-09-12 2008-08-01 Speedel Experimenta Ag Nitrate esters of aminoalcohols
EP1908471A1 (fr) 2006-10-04 2008-04-09 Speedel Experimenta AG Tétrahydropyridines comme inhibiteurs de la renine
EP1921069A1 (fr) 2006-11-08 2008-05-14 Speedel Experimenta AG Procédé de préparation de 2-alkyl-3-hétérocyclyl-prop-2-èn-1-ols
AR065792A1 (es) 2007-03-21 2009-07-01 Speedel Experimenta Ag Proceso para preparar (r o s) -5- (1 -azido-3-(6-metoxi-5-(3-metoxi-propoxi) -piridin-3-ilmetil) -4-metil- pentil) -3-alquil-dihidro-furan-2-ona
BRPI0813900A2 (pt) 2007-06-25 2014-12-30 Novartis Ag Derivados de n5-(2-etoxietil)-n3-(2-piridinil)-3,5-piperidinodicarboxa mida para uso como inibidores de renina

Also Published As

Publication number Publication date
AU2008267287A1 (en) 2008-12-31
BRPI0813900A2 (pt) 2014-12-30
CN101687847A (zh) 2010-03-31
TWI404714B (zh) 2013-08-11
JP2010531328A (ja) 2010-09-24
CL2008001872A1 (es) 2009-02-20
PE20090425A1 (es) 2009-05-12
KR101238479B1 (ko) 2013-03-04
EP2527338A1 (fr) 2012-11-28
US20080319018A1 (en) 2008-12-25
CN101687847B (zh) 2013-11-06
CA2689109A1 (fr) 2008-12-31
AR067132A1 (es) 2009-09-30
CU23842B1 (es) 2012-10-15
MA31538B1 (fr) 2010-07-01
HN2009003463A (es) 2012-12-10
WO2009000811A1 (fr) 2008-12-31
US20130005770A1 (en) 2013-01-03
EA016446B1 (ru) 2012-05-30
JP5086433B2 (ja) 2012-11-28
CR11153A (es) 2010-01-21
SG182223A1 (en) 2012-07-30
EP2527338B1 (fr) 2015-05-06
ES2541107T3 (es) 2015-07-16
IL202494A0 (en) 2010-06-30
GT200900324A (es) 2011-11-03
EP2181105B1 (fr) 2015-04-29
CU20090226A7 (es) 2012-02-15
TW200911782A (en) 2009-03-16
EP2181105A1 (fr) 2010-05-05
ES2543641T3 (es) 2015-08-20
US8383650B2 (en) 2013-02-26
EA201000037A1 (ru) 2010-06-30
KR20100023003A (ko) 2010-03-03
CO6251267A2 (es) 2011-02-21
AU2008267287B2 (en) 2012-02-16
ECSP099825A (es) 2010-01-29
NZ582098A (en) 2012-03-30
US8497286B2 (en) 2013-07-30

Similar Documents

Publication Publication Date Title
TW200738698A (en) Organic compounds
MX2007011009A (es) Compuestos de piperidina 3,4,5-substituidos.
GEP20125425B (en) Biaryl ether urea compounds
MX2009006401A (es) Derivados de indazol como inhibidores de cinasa para el tratamiento del cancer.
TNSN06411A1 (en) Pyrimidine urea derivatives as kinase inhibitors
BRPI0813244B8 (pt) compostos derivados de pirazinona, composições compreendendo ditos compostos, uso dos compostos no tratamento de doenças de pulmão e composto intermediário
MX2009010059A (es) Derivados de quinolina para el tratamiento de enfermedades inflamatorias.
PH12013501594A1 (en) Substituted indazole derivatives active as kinase inhibitors
TW200833663A (en) Therapeutic agents
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
WO2005075425A3 (fr) Derives de bisaryluree
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
WO2006072589A3 (fr) Urees disubstituees utilisees en tant qu'inhibiteurs de kinase
WO2006085113A3 (fr) Composes chimiques
WO2011127333A3 (fr) Composés pour le traitement d'une maladie, pour l'administration, et pour des compositions pharmaceutiques
EP2349279A4 (fr) Modulateurs d'aldéhyde déshydrogénase et procédés d'utilisation de ceux-ci
MX2008013212A (es) 4-anilinquinolina-3-carboxamidas como inhibidores de la cinsa csf-1r.
WO2007006534A3 (fr) Composes organiques
WO2006125621A8 (fr) Piperidines substituees utilisees comme inhibiteurs de la renine
MX2012003324A (es) Compuesto de glicina.
WO2006074924A8 (fr) Tetrahydropyridines 3,4(,5) substituees
WO2011006935A3 (fr) Dérivés de tétrazole
GB0428250D0 (en) Organic compounds
MA32406B1 (fr) Composés contenant de l'azote tricyclique et utilisation de ceux-ci comme antibactériens
WO2010121675A3 (fr) Thiazolyl-benzimidazoles
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载